Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

INTERVIEW Editor | Curator -
Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....
View Post

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

RESEARCH Editor | Curator -
Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.
View Post

2021 Psychedelic Investor Guide Released.

Psychedelic Investor Guide Editor | Curator -
Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...
View Post

Psychedelic Investor TV

INTERVIEW Editor | Curator -
To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max,...
View Post

Protected: 2021 Psychedelic Investor Guide – October

Psychedelic Investor Guide Editor | Curator -
OPEN GUIDE Updated Monthly.. Did we miss your publicly traded company?...
View Post

Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.

TESTIMONIALS Editor | Curator -
News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment...
View Post

Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the United Kingdom

CLINICS Editor | Curator -
Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq...
View Post

Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida

Featured Editor | Curator -
"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet,...
View Post

18 Psychedelic Experts Presenting (Bios).

CONFERENCES Editor | Curator -
KCSA PSYCHEDELIC INVESTOR CONFERENCE PRESENTERS Awaken (AWKN) CEO Anthony Tennyson
View Post

KCSA Psychedelics Conference. Wednesday, October 13th.

CONFERENCES Editor | Curator -
The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in...
View Post

Psychedelic Stock Review Initiates Coverage on Ehave Inc.

PSYCH STOCK NEWS Editor | Curator -
Psychedelic Stock Review Initiates Coverage on Ehave Inc. MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink:...
View Post

Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.

INTERVIEW Editor | Curator -
https://youtu.be/JXNEmACes2U?t=605 Interview start at 10:00 mark. LIVE QUOTE It...
View Post

Conference: Replay of Advances in Mental Health. M-Vest & Maxim Group LLC.

CONFERENCES Editor | Curator -
One of the best Conferences we have viewed to date, and being on replay it can be viewed at your leisure and/or...
View Post
123...7Page 1 of 7

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

INTERVIEW Editor | Curator -
Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

RESEARCH Editor | Curator -
Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.

2021 Psychedelic Investor Guide Released.

Psychedelic Investor Guide Editor | Curator -
Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.